May 20, 2021 by Ankit Nigam 0 ASCO and ESMO: Lifileucel, Pegilodecakin, GSK2857916, Checkmate 238, JnJ 61186372, Pallas trial Asco: Follow Up Of Lifileucel Treatment Abstract No : 10006 Indication : Melanoma Intervention : lifileucel (LN-144) Company : Iovance Biotherapeutics, Inc. Technology : TIL...
